Intercell AG

EANS-News: Intercell AG
Thomas Szucs elected new chairman of Intercell´s Supervisory Board

  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
Company Information

Wien (euro adhoc) - Vienna (Austria), December 30, 2011 - Intercell AG (VSE,
"ICLL") today announced that Thomas Szucs has been elected chairman of
Intercell´s Supervisory Board. He takes over the function from Michel Gréco, who
resigned from the role but still remains a member of the Supervisory Board. 

The new chairman Thomas Szucs has served as a member of Intercell´s Supervisory
Board since June 2011. He gained extensive experience in the pharmaceutical and
healthcare sector through several previous positions in acknowledged
organizations and companies. In his new role he will work with the other
Supervisory Board members to support the company in its business and scientific
strategic planning.

"The election to chairman is a great honor for me. I am looking forward to
working on the future success of the company, together with my fellow
Supervisory Board colleagues and the Management of Intercell. I want to thank
Michel Gréco for his great achievements in building this exciting company",
stated Thomas Szucs. 

The Supervisory Board of Intercell now includes the following members: Thomas
Szucs (Chairman), Ernst-Günter Afting (Vice-chairman), Michel Gréco, Alexander
von Gabain, James Sulat and Hans Wigzell.

The Board of Directors would like to take this opportunity to thank Michel
Gréco, who chaired Intercell´s Supervisory Board for more than five years, for
his dedication and commitment to the company.

"It has been a privilege to work with my fellow Supervisory Board members and
with an outstanding group of professionals in the Management Board. I trust that
Thomas Szucs will lead the company into a new era of success", says Michel

Further inquiry note:
Intercell AG
Nina Waibel
Corporate Communications
Tel. +43 1 20620-1222

end of announcement                               euro adhoc 

company:     Intercell AG
             Campus Vienna Biocenter  3
             A-1030 Wien 
phone:       +43 1 20620-0
FAX:         +43 1 20620-800
sector:      Biotechnology
ISIN:        AT0000612601
indexes:     ATX Prime
stockmarkets: official market: Wien 
language:   English

Weitere Meldungen: Intercell AG

Das könnte Sie auch interessieren: